How to treat Lung cancer?

['Lalela lelikhasi']

Ungayelapha njani umdlavuza wemaphaphu?

Kwelashwa kwemdlavuza wemaphaphu kuya ngetintfo letinyenti, letifaka ekhatsi sigaba sawo, luhlobo lwawo kanye nemphilo yesigulane.

Letinye tindlela tekwelapha letivamile tifaka ekhatsi:

1. Kuhlindvwa: Loku kuvame kuba yindlela lekahle yekwelapha umdlavuza wemaphaphu losesigabeni sekucala.

Dokotela uyalisusa lelitsumba kanye nesicu lesincane lesingasilo lesilitungeletile.

2. Kwelapha ngemisebe: Imisebe lenemandla lamakhulu isetjentiswa ekubulaleni tinhlayiya temdlavuza kanye nekunciphisa tigadla.

Ingasetjentiswa yodvwa nobe ihlanganiswe naletinye tindlela tekwelapha.

3. Kwelapha ngemakhemikhali: Lokwelapha kusebentisa imitsi kute kubulawe tinhlayiya temdlavuza.

Inganikelwa ngemlomo noma ngemlomo, futsi ivame kusetjentiswa naletinye tindlela tekwelapha.

4. Kwelapha lokugcile: Lokwelapha kuhloswe ngemagciwane latsite nobe ngemaphrotheni lafaka sandla ekukhuleni nasekuphileni kwetinhlayiya temdlavuza.

Kuvame kusetjentiswa kumdlavuza wemaphaphu loshaye kakhulu.

5. Immunotherapy: Loluhlobo lwekwelapha lusita emasotja emtimba kutsi abone futsi ahlasele tinhlayiya temdlavuza.

Kuvame kusetjentiswa kumdlavuza wemaphaphu loshaye kakhulu.

6. Photodynamic therapy: Loluhlobo lwekwelapha lusebentisa umutsi lokhanyiswa kukhanya kute kubulawe tinhlayiya temdlavuza.

Kuvame kusetjentiswa nakunesifo semdlavuza wemaphaphu losesicaleni.

7. Proton therapy: Loluhlobo lwekwelapha ngemisebe lolusebentisa emaphrothoni esikhundleni semisebe ye-x kute kuniketwe imisebe kulesimila.

Kuvame kusetjentiswa nakunesifo semdlavuza wemaphaphu losesicaleni.

8. Kuhlolwa kwetekwelashwa: Tigulane tingahle tifaneleke kuhlanganyela ekuhlolweni kwetekwelashwa lokuhlola tindlela letinsha tekwelapha nobe tinhlanganisela tato.

Kubalulekile kucoca ngelikhambi lelikahle kanye nelicembu letemphilo, njengobe luhlelo loluphumelelako lwekwelapha lutawuncika esimeni semuntfu ngamunye.

['Tintfo letibhalwe phansi']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Chen JH, Wu J, Xu Q: The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther. , 4 (): 61.

Furuse K: [Photodynamic therapy of centrally located early-stage lung cancer]. Gan To Kagaku Ryoho. 1996, 23 (1): 27-30.

Gálffy G: [From rare mutations to classical ones, inhibition of signaling pathways in non-small cell lung cancer]. Magy Onkol. 2020, 64 (3): 196-204.

Magalhães M, Alvarez-Lorenzo C, Concheiro A, Figueiras A, Santos AC, Veiga F: RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers. Expert Opin Drug Deliv. 2018, 15 (10): 965-982.

Kataoka M, Fujiwara T, Tanaka N: [Gene therapy for lung cancer]. Nihon Geka Gakkai Zasshi. 2002, 103 (2): 244-9.

Jin C, Yang B: A Case of Delayed Diagnostic Pulmonary Tuberculosis during Targeted Therapy in an EGFR Mutant Non-Small Cell Lung Cancer Patient. Case Rep Oncol. , 14 (1): 659-663.

Wang Y, Liu Q, Chen H, You J, Peng B, Cao F, Zhang X, Chen Q, Uzan G, Xu L, Zhang D: Celastrol improves the therapeutic efficacy of EGFR-TKIs for non-small-cell lung cancer by overcoming EGFR T790M drug resistance. Anticancer Drugs. 2018, 29 (8): 748-755.

['Sitatimende: setekwelapha']

['Lelikhasi langcondvomshini liniketelwe kufundzisa nekwatisa kuphela futsi alitsatsi seluleko setekwelapha nobe umsebenti wetingcweti.']

['Lemininingwane leniketwako akukafaneli isetjentiselwe kutfola nobe kwelapha tinkinga temphilo nobe tifo, futsi labo labafuna lusito lwetekwelapha kufanele batsintse dokotela lonemvume yekwenta njalo.']

['Uyacelwa kutsi ucaphele kutsi luhlelo lwekuchumana lolwakha timphendvulo temibuto, alukabi kahle kakhulu uma kukhulunywa ngetinombolo. Sibonelo, sibalo sebantfu labanesifo lesitsite.']

['Ngaso sonkhe sikhatsi cela seluleko kudokotela wakho nobe lomunye loniketa lusito lwetemphilo mayelana nesimo sakho sekugula. Ungalokotsi unganaki seluleko sebucwepheshe nobe wephute kusitfola ngenca yalokutsite lokufundze kulewebhusayithi. Uma ucabanga kutsi kungenteka unekugula, shayela 911 nobe uye egunjini lelisedvute lekuphutfuma ngekushesha. Kute budlelwane emkhatsini wetekwelapha nesigulane lobentiwa ngulewebhusayithi nobe kusetjentiswa kwayo. I-BioMedLib nobe basebenti bayo, nobe ngumuphi umuntfu lofaka sandla kulewebhusayithi, akenti nobe nguyiphi imiculu, lechazako nobe lechazako, mayelana nemniningwane loniketwe lapha nobe kusetjentiswa kwayo.']

['Liciniso: copyright']

['Umtsetfo we-Digital Millennium Copyright Act wanga-1998, 17 U.S.C. § 512 (i-DMCA) uniketa indlela yekusitwa kubanikati bemalungelo ekushicilela labakholelwa kutsi tintfo letivela ku-Internet tiphula emalungelo abo ngaphansi kwemtsetfo we-U.S. wekushicilela. ']

['Nangabe ukholelwa kutsi nobe nguyiphi intfo nobe intfo lekhona kulewebhusayithi nobe etinhlelweni tetfu yephula emalungelo akho, wena (nobe ummeli wakho) ungasitfumelela satiso ucele kutsi leyo nto nobe intfo isuswe nobe ivinjelwe.']

['Tatiso kumele titfunyelwe nge-email (buka likheli le-email kusigaba "Sekuchumana").']

['I-DMCA idzinga kutsi satiso sakho sekuhlukumeta emalungelo eluntfu sicukatse lemininingwane lelandzelako: (1) inchazelo yemsebenti logunyatwe emalungelo eluntfu lokutsiwa uphasiwe; (2) inchazelo yalokucuketfwe lokutsiwa kuphasiwe kanye nemininingwane leyenele kutsi sikhone kutfola lokucuketfwe; (3) imininingwane yekutsintsana nawe, kufaka ekhatsi likheli lakho, inombolo yelucingo nelikheli le-email; (4) sitatimende sakho sekutsi unenkolelo lenhle yekutsi lokucuketfwe ngendlela lokhonjiwe akukavumeleki kumnikati wemalungelo eluntfu, nobe kummeli wakhe, nobe ngekusebenta kwanoma ngumuphi umtsetfo; ']

['(5) sitatimende sakho, lesisayinwe ngaphasi kwesijeziso sekufunga emanga, sekutsi umniningwane lokuso satiso ucinisile nekutsi uneligunya lekuvikela emalungelo e-copyright lasolwa kutsi ephuliwe;']

['kanye (6) nekusayina ngekwemtimba nobe nge-elekthroniki kwemnikati we-copyright nobe umuntfu logunyatiwe kutsi ente umsebenti egameni lemnikati we-copyright. ']

['Kwehluleka kufaka yonkhe lemininingwane lengenhla kungaholela ekubambelekeni kwekusetjentwa kwesikhalo sakho.']

['Kuchumana']

['Sicela usitfumelele i-email nganobe nguwuphi umbuto / umbono.']

How to treat lung cancer?

The treatment for lung cancer depends on several factors, including the stage of the cancer, the type of lung cancer, and the patient's overall health.

Some common treatment options include:

1. Surgery: This is often the preferred treatment for early-stage lung cancer.

The surgeon removes the tumor and a small portion of healthy tissue around it.

2. Radiation therapy: High-energy radiation is used to kill cancer cells and shrink tumors.

It can be used alone or in combination with other treatments.

3. Chemotherapy: This treatment uses drugs to kill cancer cells.

It can be given intravenously or or orally, and is often used in combination with other treatments.

4. Targeted therapy: This treatment targets specific genes or proteins that contribute to the growth and survival of cancer cells.

It is often used for advanced or metastatic lung cancer.

5. Immunotherapy: This treatment helps the immune system recognize and attack cancer cells.

It is often used for advanced or metastatic lung cancer.

6. Photodynamic therapy: This treatment uses a light-activated drug to kill cancer cells.

It is often used for early-stage lung cancer.

7. Proton therapy: This is a type of radiation therapy that uses protons instead of x-rays to deliver radiation to the tumor.

It is often used for early-stage lung cancer.

8. Clinical trials: Patients may be eligible to participate in clinical trials testing new treatments or combinations of treatments.

It is important to discuss the best treatment options with a healthcare team, as the most effective treatment plan will depend on the individual's specific situation.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.